Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
ImmuCell Corporation (ICCC) had Non-Operating Income/Expense of $0.33M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$8.07M |
|
$1.45M |
|
$4.71M |
|
$3.35M |
|
$6.95M |
|
$1.12M |
|
|
Non-Operating Income/Expense |
$0.33M |
$1.45M |
|
$1.45M |
|
$1.45M |
|
$1.45M |
|
$1.45M |
|
$1.45M |
|
$1.12M |
|
$1.80M |
|
8.98M |
|
8.98M |
|
$0.16 |
|
$0.16 |
|
| Balance Sheet Financials | |
$15.92M |
|
$25.02M |
|
$29.70M |
|
$45.62M |
|
$3.87M |
|
$8.65M |
|
$12.76M |
|
$16.63M |
|
$28.99M |
|
$28.88M |
|
$28.99M |
|
8.98M |
|
| Cash Flow Statement Financials | |
$1.57M |
|
$-0.33M |
|
$-0.40M |
|
$3.76M |
|
$4.60M |
|
$0.84M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.12 |
|
-- |
|
-- |
|
0.23 |
|
0.35 |
|
41.58% |
|
13.85% |
|
13.85% |
|
-- |
|
17.96% |
|
17.94% |
|
$1.24M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.64 |
|
2.41 |
|
37.33 |
|
4.99% |
|
5.01% |
|
3.17% |
|
3.84% |
|
$3.23 |
|
$0.14 |
|
$0.18 |
|